Extract notice to the Minister

Auro-Dapagliflozin

Common name / Subject : dapagliflozine (insuffisance cardiaque, fraction d'éjection >40%)
Name of the manufacturer : AuroPharma
Form : Co.
Dosage : 5 mg, 10 mg

Indication :

INESSS' Recommendation
Inscription - Sous conditions

Minister's decisions
À venir

Evaluation published on September 09, 2026

Subscribe to our newsletter now

Subscription